MM2 Group as announced that its wholly owned subsidiary, Genotec Nutritionals, a New York-based nutraceutical company, has entered into a partnership with Chinese drug maker Anshi Pharmaceuticals to manufacture sofgel capsules in Zhongsan City, China.
The current capacity of the state of the art plant is 1.5 billion capsules per year, and is capable of expanding capacity to 5 billion sofgel capsules per year.
Mark Meller, CEO of MM2 Group, commented, "We have already met with some of the largest users of sofgels in the nutritional supplement market. Our current focus is to supply large quantities of Vitamin E capsules to several users. We are now negotiating supply agreements with various companies, and hope to be in a position to make several exciting announcements in the near future regarding sales activity from this new venture."
MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies.